{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T04:14:32Z","timestamp":1781669672618,"version":"3.54.5"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T00:00:00Z","timestamp":1626825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T00:00:00Z","timestamp":1626825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Chulalongkorn University and the Thailand Research Fund","award":["RTA6280004"],"award-info":[{"award-number":["RTA6280004"]}]},{"DOI":"10.13039\/501100004192","name":"National Science and Technology Development Agency","doi-asserted-by":"publisher","award":["FDA-CO-2561-8477-TH"],"award-info":[{"award-number":["FDA-CO-2561-8477-TH"]}],"id":[{"id":"10.13039\/501100004192","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ratchadapiseksomphot Fund for Postdoctoral Fellowship and Development of New Faculty Staff"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Early detection improves survival and increases curative probability in hepatocellular carcinoma (HCC). Peripheral blood mononuclear cells (PBMCs) can provide an inexpensive, less-invasive and highly accurate method. The objective of this study is to find the potential marker for HCC screening, utilizing gene expression of the PBMCs. Data from the NCBI GEO database of gene expression in HCC patients and healthy donor's PBMCs was collected. As a result, GSE 49515 and GSE 58208 were found. Using both, a statistical significance test was conducted in each gene expression of each data set which resulted in 187 genes. We randomized three selected genes (FLNA, CAP1, and CLU) from the significant\n                    <jats:italic>p<\/jats:italic>\n                    -value group (\n                    <jats:italic>p<\/jats:italic>\n                    -values\u2009&lt;\u20090.001). Then, a total of 76 healthy donors, 153 HCC, 20 hepatic fibrosis, 20 non-alcoholic fatty liver were collected. Quantitative RT-PCR (qRT-PCR) was performed in cDNA from all blood samples from the qRT-PCR, The Cycle threshold (Ct) value of FLNA, CLU, CAP1 of HCC group (28.47\u2009\u00b1\u20094.43, 28.01\u2009\u00b1\u20093.75, 29.64\u2009\u00b1\u20093.90) were lower than healthy group (34.23\u2009\u00b1\u20093.54, 32.90\u2009\u00b1\u20094.15, 32.18\u2009\u00b1\u20095.02) (\n                    <jats:italic>p<\/jats:italic>\n                    -values\u2009&lt;\u20090.0001). The accuracy, sensitivity and specificity of these genes as a screening tool were: FLNA (80.8%, 88.0%, 65.8%), CLU (63.4%, 93.3%, 31.3%), CAP1 (67.2%, 83.3%, 39.1%). The tests were performed in two and three gene combinations. Results demonstrated high accuracy of 86.2%, sensitivity of 85% and specificity of 88.4% in the FLNA and CLU combination. Furthermore, after analyzed using hepatic fibrosis and non-alcoholic fatty liver as a control, the FLNA and CLU combination is shown to have accuracy of 76.9%, sensitivity of 77.6% and specificity of 75%. Also, we founded that our gene combination performs better than the current gold standard for HCC screening. We concluded that FLNA and CLU combination have high potential for being HCC novel markers. Combined with current tumor markers, further research of the gene\u2019s expression might help identify more potential markers and improve diagnosis methods.\n                  <\/jats:p>","DOI":"10.1038\/s41598-021-94330-1","type":"journal-article","created":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T06:07:53Z","timestamp":1626847673000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["The expression of FLNA and CLU in PBMCs as a novel screening marker for hepatocellular carcinoma"],"prefix":"10.1038","volume":"11","author":[{"given":"Rathasapa","family":"Patarat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoji","family":"Riku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pattapon","family":"Kunadirek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natthaya","family":"Chuaypen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pisit","family":"Tangkijvanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apiwat","family":"Mutirangura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charoenchai","family":"Puttipanyalears","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,21]]},"reference":[{"key":"94330_CR1","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","volume":"16","author":"JD Yang","year":"2019","unstructured":"Yang, J. D. et al. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat. Rev. Gastroenterol. Hepatol. 16, 589\u2013604. https:\/\/doi.org\/10.1038\/s41575-019-0186-y (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"6","key":"94330_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68(6), 394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492 (2018).","journal-title":"CA Cancer J. Clin."},{"issue":"8","key":"94330_CR3","doi-asserted-by":"publisher","first-page":"3567","DOI":"10.7314\/apjcp.2014.15.8.3567","volume":"15","author":"K Somboon","year":"2014","unstructured":"Somboon, K., Siramolpiwat, S. & Vilaichone, R. K. Epidemiology and survival of hepatocellular carcinoma in the central region of Thailand, Asian. Pac. J. Cancer Prev. 15(8), 3567\u20133570. https:\/\/doi.org\/10.7314\/apjcp.2014.15.8.3567 (2014).","journal-title":"Pac. J. Cancer Prev."},{"issue":"6","key":"94330_CR4","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1067\/j.cpradiol.2015.04.004","volume":"44","author":"T Clark","year":"2015","unstructured":"Clark, T., Maximin, S., Meier, J., Pokharel, S. & Bhargava, P. Hepatocellular carcinoma: Review of epidemiology, screening, imaging diagnosis, response assessment, and treatment. Curr. Probl. Diagn. Radiol. 44(6), 479\u2013486. https:\/\/doi.org\/10.1067\/j.cpradiol.2015.04.004 (2015).","journal-title":"Curr. Probl. Diagn. Radiol."},{"issue":"2","key":"94330_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0228857","volume":"15","author":"J Zhang","year":"2020","unstructured":"Zhang, J. et al. The threshold of alpha-fetoprotein (AFP) for the diagnosis of hepatocellular carcinoma: A systematic review and meta-analysis. PLoS ONE 15(2), e0228857. https:\/\/doi.org\/10.1371\/journal.pone.0228857 (2020).","journal-title":"PLoS ONE"},{"issue":"12","key":"94330_CR6","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1007\/s10620-010-1201-x","volume":"55","author":"FM Sanai","year":"2010","unstructured":"Sanai, F. M. et al. Assessment of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma in Middle Eastern patients. Dig. Dis. Sci. 55(12), 3568\u20133575. https:\/\/doi.org\/10.1007\/s10620-010-1201-x (2010).","journal-title":"Dig. Dis. Sci."},{"issue":"4","key":"94330_CR7","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/hpb.12146","volume":"16","author":"SL Chan","year":"2014","unstructured":"Chan, S. L. et al. Performance of serum \u03b1-fetoprotein levels in the diagnosis of hepatocellular carcinoma in patients with a hepatic mass. HPB (Oxford) 16(4), 366\u2013372. https:\/\/doi.org\/10.1111\/hpb.12146 (2014).","journal-title":"HPB (Oxford)"},{"issue":"3","key":"94330_CR8","first-page":"201","volume":"4","author":"S Amit","year":"2008","unstructured":"Amit, S. & Jorge, A. M. Screening for hepatocellular carcinoma. Gastroenterol. Hepatol. (N.Y.) 4(3), 201\u2013208 (2008).","journal-title":"Gastroenterol. Hepatol. (N.Y.)"},{"issue":"4","key":"94330_CR9","doi-asserted-by":"publisher","first-page":"475","DOI":"10.2217\/epi-2015-0007","volume":"8","author":"C Puttipanyalears","year":"2016","unstructured":"Puttipanyalears, C., Kitkumthorn, N., Buranapraditkun, S., Keelawat, S. & Mutirangura, A. Breast cancer upregulating genes in stromal cells by LINE-1 hypermethylation and micrometastatic detection. Epigenomics 8(4), 475\u2013486. https:\/\/doi.org\/10.2217\/epi-2015-0007 (2016).","journal-title":"Epigenomics"},{"key":"94330_CR10","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13058-017-0886-6","volume":"19","author":"SR Sturgeon","year":"2017","unstructured":"Sturgeon, S. R. et al. White blood cell DNA methylation and risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO). Breast Cancer Res. 19, 94. https:\/\/doi.org\/10.1186\/s13058-017-0886-6 (2017).","journal-title":"Breast Cancer Res."},{"key":"94330_CR11","doi-asserted-by":"publisher","first-page":"11201","DOI":"10.1038\/s41598-021-90515-w","volume":"11","author":"P Kunadirek","year":"2021","unstructured":"Kunadirek, P. et al. Identification of BHLHE40 expression in peripheral blood mononuclear cells as a novel biomarker for diagnosis and prognosis of hepatocellular carcinoma. Sci Rep. 11, 11201. https:\/\/doi.org\/10.1038\/s41598-021-90515-w (2021).","journal-title":"Sci Rep."},{"issue":"3","key":"94330_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0230905","volume":"15","author":"S Chen","year":"2020","unstructured":"Chen, S. et al. Identification of human peripheral blood monocyte gene markers for early screening of solid tumors. PLoS ONE 15(3), e0230905. https:\/\/doi.org\/10.1371\/journal.pone.0230905 (2020).","journal-title":"PLoS ONE"},{"issue":"6","key":"94330_CR13","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.apjtm.2016.04.019","volume":"9","author":"CJ Lei","year":"2016","unstructured":"Lei, C. J. et al. Change of the peripheral blood immune pattern and its correlation with prognosis in patients with liver cancer treated by sorafenib. Asian Pac. J. Trop. Med. 9(6), 592\u2013596. https:\/\/doi.org\/10.1016\/j.apjtm.2016.04.019 (2016).","journal-title":"Asian Pac. J. Trop. Med."},{"issue":"5","key":"94330_CR14","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.ejca.2013.11.026","volume":"50","author":"M Shi","year":"2014","unstructured":"Shi, M. et al. A blood-based three-gene signature for the non-invasive detection of early human hepatocellular carcinoma. Eur. J. Cancer 50(5), 928\u2013936. https:\/\/doi.org\/10.1016\/j.ejca.2013.11.026 (2014).","journal-title":"Eur. J. Cancer"},{"issue":"3","key":"94330_CR15","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.3892\/ol.2019.10638","volume":"18","author":"P Boonsongserm","year":"2019","unstructured":"Boonsongserm, P. et al. Tumor-induced DNA methylation in the white blood cells of patients with colorectal cancer. Oncol. Lett. 18(3), 3039\u20133048. https:\/\/doi.org\/10.3892\/ol.2019.10638 (2019).","journal-title":"Oncol. Lett."},{"issue":"2","key":"94330_CR16","doi-asserted-by":"publisher","first-page":"981","DOI":"10.4103\/0973-1482.154081","volume":"12","author":"JX Jiang","year":"2016","unstructured":"Jiang, J. X. et al. Insights into significant pathways and gene interaction networks in peripheral blood mononuclear cells for early diagnosis of hepatocellular carcinoma. J. Cancer Res. Ther. 12(2), 981\u2013989. https:\/\/doi.org\/10.4103\/0973-1482.154081 (2016).","journal-title":"J. Cancer Res. Ther."},{"key":"94330_CR17","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/s41598-020-79622-2","volume":"11","author":"C Puttipanyalears","year":"2021","unstructured":"Puttipanyalears, C. et al. Quantitative STAU2 measurement in lymphocytes for breast cancer risk assessment. Sci. Rep. 11, 915. https:\/\/doi.org\/10.1038\/s41598-020-79622-2 (2021).","journal-title":"Sci. Rep."},{"key":"94330_CR18","unstructured":"Hui, K. M. Expression profiling of PBMC from patients with hepatocellular carcinoma. Gene Expression Omnibus. https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE49515 (2013)."},{"key":"94330_CR19","unstructured":"Hui, K. M. Gene expression profiling of PBMC from normal individuals, chronic hepatitis B carriers and hepatocellular carcinoma patients. Gene Expression Omnibus. https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE58208 (2014)."},{"issue":"12","key":"94330_CR20","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1158\/2326-6066.CIR-14-0160","volume":"2","author":"MT Chow","year":"2014","unstructured":"Chow, M. T. & Luster, A. D. Chemokines in cancer. Cancer Immunol. Res. 2(12), 1125\u20131131. https:\/\/doi.org\/10.1158\/2326-6066.CIR-14-0160 (2014).","journal-title":"Cancer Immunol. Res."},{"issue":"2","key":"94330_CR21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.canlet.2007.05.013","volume":"256","author":"D Raman","year":"2007","unstructured":"Raman, D., Baugher, P. J., Thu, Y. M. & Richmond, A. Role of chemokines in tumor growth. Cancer Lett. 256(2), 137\u2013165. https:\/\/doi.org\/10.1016\/j.canlet.2007.05.013 (2007).","journal-title":"Cancer Lett."},{"issue":"1","key":"94330_CR22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12943-020-01294-3","volume":"20","author":"AA Bhat","year":"2021","unstructured":"Bhat, A. A. et al. Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy. Mol. Cancer 20(1), 2. https:\/\/doi.org\/10.1186\/s12943-020-01294-3 (2021).","journal-title":"Mol. Cancer"},{"issue":"1","key":"94330_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrc1252","volume":"4","author":"G Dranoff","year":"2004","unstructured":"Dranoff, G. Cytokines in cancer pathogenesis and cancer therapy. Nat. Rev. Cancer 4(1), 11\u201322. https:\/\/doi.org\/10.1038\/nrc1252 (2004).","journal-title":"Nat. Rev. Cancer"},{"issue":"27","key":"94330_CR24","doi-asserted-by":"publisher","first-page":"16072","DOI":"10.1073\/pnas.1918937117","volume":"117","author":"JI Griffiths","year":"2020","unstructured":"Griffiths, J. I. et al. Circulating immune cell phenotype dynamics reflect the strength of tumor-immune cell interactions in patients during immunotherapy. Proc. Natl. Acad. Sci. U.S.A. 117(27), 16072\u201316082. https:\/\/doi.org\/10.1073\/pnas.1918937117 (2020).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"94330_CR25","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s002620050505","volume":"47","author":"DB Chappell","year":"1998","unstructured":"Chappell, D. B. & Restifo, N. P. T cell-tumor cell: A fatal interaction?. Cancer Immunol. Immunother.: CII 47(2), 65\u201371. https:\/\/doi.org\/10.1007\/s002620050505 (1998).","journal-title":"Cancer Immunol. Immunother.: CII"},{"issue":"10","key":"94330_CR26","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/emmm.201100165","volume":"3","author":"K Karwacz","year":"2011","unstructured":"Karwacz, K. et al. PD-L1 co-stimulation contributes to ligand-induced T cell receptor down-modulation on CD8+ T cells. EMBO Mol. Med. 3(10), 581\u2013592. https:\/\/doi.org\/10.1002\/emmm.201100165 (2011).","journal-title":"EMBO Mol. Med."},{"issue":"2","key":"94330_CR27","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1046\/j.1365-2567.2000.00121.x","volume":"101","author":"DM Sansom","year":"2000","unstructured":"Sansom, D. M. CD28, CTLA-4 and their ligands: Who does what and to whom?. Immunology 101(2), 169\u2013177. https:\/\/doi.org\/10.1046\/j.1365-2567.2000.00121.x (2000).","journal-title":"Immunology"},{"key":"94330_CR28","doi-asserted-by":"publisher","first-page":"558248","DOI":"10.3389\/fonc.2021.558248","volume":"11","author":"VAB de Lima","year":"2021","unstructured":"de Lima, V. A. B. et al. Immune cell profiling of peripheral blood as signature for response during checkpoint inhibition across cancer types. Front. Oncol. 11, 558248. https:\/\/doi.org\/10.3389\/fonc.2021.558248 (2021).","journal-title":"Front. Oncol."},{"issue":"5","key":"94330_CR29","doi-asserted-by":"publisher","first-page":"5399","DOI":"10.3892\/ol.2019.10903","volume":"18","author":"Y Zheng","year":"2019","unstructured":"Zheng, Y., Fang, Y. C. & Li, J. PD-L1 expression levels on tumor cells affect their immunosuppressive activity. Oncol. Lett. 18(5), 5399\u20135407. https:\/\/doi.org\/10.3892\/ol.2019.10903 (2019).","journal-title":"Oncol. Lett."},{"issue":"4","key":"94330_CR30","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1152\/japplphysiol.00316.2004","volume":"97","author":"PH Connolly","year":"2004","unstructured":"Connolly, P. H. et al. Effects of exercise on gene expression in human peripheral blood mononuclear cells. J. Appl. Physiol. 97(4), 1461\u20131469. https:\/\/doi.org\/10.1152\/japplphysiol.00316.2004 (2004).","journal-title":"J. Appl. Physiol."},{"issue":"1","key":"94330_CR31","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/BF02931167","volume":"1","author":"C Inoue","year":"1996","unstructured":"Inoue, C., Takeshita, T., Kondo, H. & Morimoto, K. Cigarette smoking is associated with the reduction of lymphokine-activated killer cell and natural killer cell activities. Environ. Health Prev. Med. 1(1), 14\u201319. https:\/\/doi.org\/10.1007\/BF02931167 (1996).","journal-title":"Environ. Health Prev. Med."},{"issue":"5","key":"94330_CR32","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3390\/ijerph15051021","volume":"15","author":"J Wieczfinska","year":"2018","unstructured":"Wieczfinska, J., Kowalczyk, T., Sitarek, P., Ska\u0142a, E. & Pawliczak, R. Analysis of short-term smoking effects in PBMC of healthy subjects-preliminary study. Int. J. Environ. Res. Public Health 15(5), 1021. https:\/\/doi.org\/10.3390\/ijerph15051021 (2018).","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"17","key":"94330_CR33","doi-asserted-by":"publisher","first-page":"8141","DOI":"10.1021\/jf801034k","volume":"56","author":"YM Tseng","year":"2008","unstructured":"Tseng, Y. M. et al. Effects of alcohol-induced human peripheral blood mononuclear cell (PBMC) pretreated whey protein concentrate (WPC) on oxidative damage. J. Agric. Food Chem. 56(17), 8141\u20138147. https:\/\/doi.org\/10.1021\/jf801034k (2008).","journal-title":"J. Agric. Food Chem."},{"issue":"1","key":"94330_CR34","doi-asserted-by":"publisher","first-page":"7847","DOI":"10.1038\/s41598-019-44302-3","volume":"9","author":"S Sureshchandra","year":"2019","unstructured":"Sureshchandra, S. et al. Dose-dependent effects of chronic alcohol drinking on peripheral immune responses. Sci. Rep. 9(1), 7847. https:\/\/doi.org\/10.1038\/s41598-019-44302-3 (2019).","journal-title":"Sci. Rep."},{"key":"94330_CR35","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jpsychires.2017.02.005","volume":"89","author":"B Roy","year":"2017","unstructured":"Roy, B., Shelton, R. C. & Dwivedi, Y. DNA methylation and expression of stress related genes in PBMC of MDD patients with and without serious suicidal ideation. J. Psychiatry Res. 89, 115\u2013124. https:\/\/doi.org\/10.1016\/j.jpsychires.2017.02.005 (2017).","journal-title":"J. Psychiatry Res."},{"issue":"2","key":"94330_CR36","doi-asserted-by":"publisher","first-page":"160","DOI":"10.4161\/cam.5.2.14401","volume":"5","author":"F Nakamura","year":"2011","unstructured":"Nakamura, F., Stossel, T. P. & Hartwig, J. H. The filamins: Organizers of cell structure and function. Cell Adhes. Migr. 5(2), 160\u2013169. https:\/\/doi.org\/10.4161\/cam.5.2.14401 (2011).","journal-title":"Cell Adhes. Migr."},{"issue":"2","key":"94330_CR37","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4161\/spmg.20223","volume":"2","author":"W Su","year":"2012","unstructured":"Su, W., Mruk, D. D. & Cheng, C. Y. Filamin A: A regulator of blood-testis barrier assembly during post-natal development. Spermatogenesis 2(2), 73\u201378 (2012).","journal-title":"Spermatogenesis"},{"key":"94330_CR38","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/2045-3701-3-7","volume":"3","author":"J Yue","year":"2013","unstructured":"Yue, J., Huhn, S. & Shen, Z. Complex roles of filamin-A mediated cytoskeleton network in cancer progression. Cell Biosci. 3, 7. https:\/\/doi.org\/10.1186\/2045-3701-3-7 (2013).","journal-title":"Cell Biosci."},{"issue":"2","key":"94330_CR39","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/liv.13522","volume":"38","author":"M Donadon","year":"2018","unstructured":"Donadon, M. et al. Filamin A expression predicts early recurrence of hepatocellular carcinoma after hepatectomy. Liver Int. 38(2), 303\u2013311. https:\/\/doi.org\/10.1111\/liv.13522 (2018).","journal-title":"Liver Int."},{"issue":"3\u20134","key":"94330_CR40","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1159\/000327946","volume":"27","author":"J Ai","year":"2011","unstructured":"Ai, J. et al. FLNA and PGK1 are two potential markers for progression in hepatocellular carcinoma. Cell Physiol. Biochem. 27(3\u20134), 207\u2013216. https:\/\/doi.org\/10.1159\/000327946 (2011).","journal-title":"Cell Physiol. Biochem."},{"issue":"3","key":"94330_CR41","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.4049\/jimmunol.177.3.1721","volume":"177","author":"K Hayashi","year":"2006","unstructured":"Hayashi, K. & Altman, A. Filamin A is required for T cell activation mediated by protein kinase C-theta. J. Immunol. 177(3), 1721\u20131728. https:\/\/doi.org\/10.4049\/jimmunol.177.3.1721 (2006).","journal-title":"J. Immunol."},{"issue":"6","key":"94330_CR42","doi-asserted-by":"publisher","first-page":"R341","DOI":"10.1530\/ERC-13-0364","volume":"20","author":"RM Savoy","year":"2013","unstructured":"Savoy, R. M. & Ghosh, P. M. The dual role of filamin A in cancer: Can\u2019t live with (too much of) it, can\u2019t live without it. Endocr. Relat. Cancer. 20(6), R341\u2013R356. https:\/\/doi.org\/10.1530\/ERC-13-0364 (2013).","journal-title":"Endocr. Relat. Cancer."},{"issue":"5","key":"94330_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.113","volume":"7","author":"P Cunin","year":"2016","unstructured":"Cunin, P. et al. Clusterin facilitates apoptotic cell clearance and prevents apoptotic cell-induced autoimmune responses. Cell Death Dis. 7(5), e2215. https:\/\/doi.org\/10.1038\/cddis.2016.113 (2016).","journal-title":"Cell Death Dis."},{"issue":"9","key":"94330_CR44","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/ncb1291","volume":"7","author":"H Zhang","year":"2005","unstructured":"Zhang, H. et al. Clusterin inhibits apoptosis by interacting with activated Bax. Nat. Cell Biol. 7(9), 909\u2013915. https:\/\/doi.org\/10.1038\/ncb1291 (2005).","journal-title":"Nat. Cell Biol."},{"issue":"12","key":"94330_CR45","doi-asserted-by":"publisher","first-page":"7714","DOI":"10.1016\/S0021-9258(18)32238-5","volume":"258","author":"O Blaschuk","year":"1983","unstructured":"Blaschuk, O., Burdzy, K. & Fritz, I. B. Purification and characterization of a cell-aggregating factor (clusterin), the major glycoprotein in ram rete testis fluid. J. Biol. Chem. 258(12), 7714\u20137720 (1983).","journal-title":"J. Biol. Chem."},{"key":"94330_CR46","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1038\/sj.onc.1209141","volume":"25","author":"S Lau","year":"2006","unstructured":"Lau, S. et al. Clusterin plays an important role in hepatocellular carcinoma metastasis. Oncogene 25, 1242\u20131250. https:\/\/doi.org\/10.1038\/sj.onc.1209141 (2006).","journal-title":"Oncogene"},{"issue":"5","key":"94330_CR47","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.18632\/oncotarget.3093","volume":"6","author":"C Wang","year":"2015","unstructured":"Wang, C. et al. Clusterin facilitates metastasis by EIF3I\/Akt\/MMP13 signaling in hepatocellular carcinoma. Oncotarget 6(5), 2903\u20132916. https:\/\/doi.org\/10.18632\/oncotarget.3093 (2015).","journal-title":"Oncotarget"},{"issue":"5","key":"94330_CR48","doi-asserted-by":"publisher","first-page":"7191","DOI":"10.3892\/ol.2018.8186","volume":"15","author":"J Zhong","year":"2018","unstructured":"Zhong, J. et al. Therapeutic role of meloxicam targeting secretory clusterin-mediated invasion in hepatocellular carcinoma cells. Oncol. Lett. 15(5), 7191\u20137199. https:\/\/doi.org\/10.3892\/ol.2018.8186 (2018).","journal-title":"Oncol. Lett."},{"issue":"5","key":"94330_CR49","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.3892\/ijmm.2018.3463","volume":"41","author":"J Zhong","year":"2018","unstructured":"Zhong, J. et al. Downregulation of secreted clusterin potentiates the lethality of sorafenib in hepatocellular carcinoma in association with the inhibition of ERK1\/2 signals. Int. J. Mol. Med. 41(5), 2893\u20132900. https:\/\/doi.org\/10.3892\/ijmm.2018.3463 (2018).","journal-title":"Int. J. Mol. Med."},{"issue":"5","key":"94330_CR50","doi-asserted-by":"publisher","first-page":"3995","DOI":"10.1007\/s13277-015-3043-9","volume":"36","author":"W Zheng","year":"2015","unstructured":"Zheng, W. et al. Silencing clusterin gene transcription on effects of multidrug resistance reversing of human hepatoma HepG2\/ADM cells. Tumour Biol. 36(5), 3995\u20134003. https:\/\/doi.org\/10.1007\/s13277-015-3043-9 (2015).","journal-title":"Tumour Biol."},{"issue":"4","key":"94330_CR51","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/j.1365-2567.2006.02321.x","volume":"117","author":"A Taylor","year":"2006","unstructured":"Taylor, A., Verhagen, J., Blaser, K., Akdis, M. & Akdis, C. A. Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells. Immunology 117(4), 433\u2013442. https:\/\/doi.org\/10.1111\/j.1365-2567.2006.02321.x (2006).","journal-title":"Immunology"},{"issue":"Pt 15","key":"94330_CR52","doi-asserted-by":"publisher","first-page":"3249","DOI":"10.1242\/jcs.128231","volume":"126","author":"S Ono","year":"2013","unstructured":"Ono, S. The role of cyclase-associated protein in regulating actin filament dynamics - more than a monomer-sequestration factor. J. Cell Sci. 126(Pt 15), 3249\u20133258. https:\/\/doi.org\/10.1242\/jcs.128231 (2013).","journal-title":"J. Cell Sci."},{"issue":"3","key":"94330_CR53","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.prp.2013.11.011","volume":"210","author":"Y Liu","year":"2014","unstructured":"Liu, Y. et al. Upregulated expression of CAP1 is associated with tumor migration and metastasis in hepatocellular carcinoma. Pathol. Res. Pract. 210(3), 169\u2013175. https:\/\/doi.org\/10.1016\/j.prp.2013.11.011 (2014).","journal-title":"Pathol. Res. Pract."},{"issue":"4","key":"94330_CR54","doi-asserted-by":"publisher","first-page":"941","DOI":"10.3892\/ijmm.2015.2089","volume":"35","author":"M Hua","year":"2015","unstructured":"Hua, M. et al. CAP1 is overexpressed in human epithelial ovarian cancer and promotes cell proliferation. Int. J. Mol.. Med. 35(4), 941\u2013949. https:\/\/doi.org\/10.3892\/ijmm.2015.2089 (2015).","journal-title":"Int. J. Mol.. Med."},{"issue":"3","key":"94330_CR55","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.cmet.2014.01.013","volume":"19","author":"S Lee","year":"2014","unstructured":"Lee, S. et al. Adenylyl cyclase-associated protein 1 is a receptor for human resistin and mediates inflammatory actions of human monocytes. Cell Metab. 19(3), 484\u2013497. https:\/\/doi.org\/10.1016\/j.cmet.2014.01.013 (2014).","journal-title":"Cell Metab."},{"issue":"3","key":"94330_CR56","doi-asserted-by":"publisher","first-page":"121","DOI":"10.4103\/aam.aam_56_18","volume":"18","author":"N Singh","year":"2019","unstructured":"Singh, N. et al. Inflammation and cancer. Ann. Afr. Med. 18(3), 121\u2013126. https:\/\/doi.org\/10.4103\/aam.aam_56_18 (2019).","journal-title":"Ann. Afr. Med."},{"issue":"2","key":"94330_CR57","doi-asserted-by":"publisher","first-page":"257","DOI":"10.5372\/1905-7415.0502.034","volume":"5","author":"C Aporntewan","year":"2011","unstructured":"Aporntewan, C. & Mutirangura, A. Connection up- and down-regulation expression analysis of microarrays (CU-DREAM): A physiogenomic discovery tool. Asian Biomed. 5(2), 257\u2013262. https:\/\/doi.org\/10.5372\/1905-7415.0502.034 (2011).","journal-title":"Asian Biomed."},{"issue":"15","key":"94330_CR58","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gks596","volume":"40","author":"A Untergasser","year":"2012","unstructured":"Untergasser, A. et al. Primer3\u2014New capabilities and interfaces. Nucleic Acids Res. 40(15), e115. https:\/\/doi.org\/10.1093\/nar\/gks596 (2012).","journal-title":"Nucleic Acids Res."},{"key":"94330_CR59","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/1471-2105-13-134","volume":"13","author":"J Ye","year":"2012","unstructured":"Ye, J. et al. Primer-BLAST: A tool to design target-specific primers for polymerase chain reaction. BMC Bioinform. 13, 134. https:\/\/doi.org\/10.1186\/1471-2105-13-134 (2012).","journal-title":"BMC Bioinform."},{"issue":"3","key":"94330_CR60","first-page":"71","volume":"3","author":"X Rao","year":"2013","unstructured":"Rao, X., Huang, X., Zhou, Z. & Lin, X. An improvement of the 2\u02c6(\u2212delta delta CT) method for quantitative real-time polymerase chain reaction data analysis. Biostat. Bioinform. Biomath. 3(3), 71\u201385 (2013).","journal-title":"Biostat. Bioinform. Biomath."},{"key":"94330_CR61","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41592-019-0686-2","volume":"17","author":"P Virtanen","year":"2020","unstructured":"Virtanen, P. et al. SciPy 1.0: Fundamental algorithms for scientific computing in Python. Nat. Methods 17, 261\u2013272. https:\/\/doi.org\/10.1038\/s41592-019-0686-2 (2020).","journal-title":"Nat. Methods"},{"key":"94330_CR62","doi-asserted-by":"crossref","unstructured":"McKinney, W. Data Structures for Statistical Computing in Python. Preprint at https:\/\/conference.scipy.org\/proceedings\/scipy2010\/mckinney.html (2010).","DOI":"10.25080\/Majora-92bf1922-00a"},{"issue":"3","key":"94330_CR63","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1109\/MCSE.2007.55","volume":"9","author":"JD Hunter","year":"2007","unstructured":"Hunter, J. D. Matplotlib: A 2D graphics environment. Comput. Sci. Eng. 9(3), 90\u201395. https:\/\/doi.org\/10.1109\/MCSE.2007.55 (2007).","journal-title":"Comput. Sci. Eng."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-94330-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-94330-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-94330-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T06:27:47Z","timestamp":1670048867000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-94330-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,21]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["94330"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-94330-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-242945\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,21]]},"assertion":[{"value":"15 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14838"}}